Skip to main content
MNKD logo
MNKD
(NASDAQ)
MannKind Corporation
$2.50-- (--)
Loading... - Market loading

MannKind Corporation (MNKD) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for MannKind Corporation stock.

Analyst Consensus Rating

Investment consensus from 4 professional research analysts

Consensus Rating

Buy
Based on 4 unique analysts
(6 total ratings in last 90 days)
Low Confidence:1 Buy/Sell

Average Price Target

$6.63
165.20% Upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest MNKD Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Yun Zhong
Wedbush
BuyMaintains
$10.00 $8.00
Brandon Folkes
HC Wainwright
Strong BuyMaintains
$11.00 $8.00
Benjamin Burnett
Wells Fargo
BuyMaintains
$8.00 $7.00
Douglas Miehm
RBC Capital
HoldDowngrades
$7.50 $3.50
Brandon Folkes
HC Wainwright
Strong BuyReiterates
$11.00 $11.00
Brandon Folkes
HC Wainwright
Strong BuyReiterates
$11.00 $11.00

Frequently Asked Questions

What is the analyst consensus rating for MNKD?

The analyst consensus rating for MNKD is "Buy" based on 4 analyst recommendations.

What is the average price target for MNKD?

The average 12-month price target for MNKD is $6.63, representing an upside of 165.2% from the current price of $2.50.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.